CN Patent
CN119033777A — 用于控制海虱的二氢异噁唑化合物
Assigned to Intervet International BV · Expires 2024-11-29 · 1y expired
What this patent protects
本发明涉及用于控制海虱的二氢异噁唑化合物。本发明涉及可注射的异噁唑啉药物组合物及其针对寄生虫侵袭的用途。本发明提供下式的二氢异噁唑: 或其盐,用于控制鱼类中的海虱。
USPTO Abstract
本发明涉及用于控制海虱的二氢异噁唑化合物。本发明涉及可注射的异噁唑啉药物组合物及其针对寄生虫侵袭的用途。本发明提供下式的二氢异噁唑: 或其盐,用于控制鱼类中的海虱。
Drugs covered by this patent
- Xdemvy (LOTILANER) · Tarsus
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.